EVK Stock Chart & Stats
CHF15.76
CHF0.00(0.00%)
At close: 4:00 PM EDT
CHF15.76
CHF0.00(0.00%)
Day’s Range― - ―
52-Week RangeCHF11.96 - CHF35.89
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
CHF6.72B
Enterprise ValueCHF10.92B
Total Cash (Recent Filing)CHF589.00M
Total Debt (Recent Filing)CHF4.16B
Price to Earnings (P/E)46.3
Beta0.13
Next Earnings
Aug 04, 2026EPS Estimate
0.48Next Dividend Ex-DateN/A
Dividend Yield3.05%
Share Statistics
EPS (TTM)0.34
Shares Outstanding466,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.25
Price to Book (P/B)0.77
Price to Sales (P/S)0.44
P/FCF Ratio8.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF16.02Price Target Upside1.62% Upside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)1.39
Revenue Forecast (FY)CHF13.36B
Bulls Say, Bears Say
Bulls Say
Financial GuidanceThe CEO expressed confidence in the FY-25 guidance, with a solid start in Q1 and expectations for EBITDA to increase year-over-year.
Market PositionEvonik is resilient to US tariffs, as the company benefits from high tariffs on Chinese methionine imports to the US.
Bears Say
Industry ChallengesStructural changes in the European chemical industry indicate that 15-20% of value chains are lost and will not return, leading to plant closures.
Evonik News
EVK FAQ
What was Evonik’s price range in the past 12 months?
Evonik lowest stock price was CHF11.96 and its highest was CHF35.89 in the past 12 months.
What is Evonik’s market cap?
Evonik’s market cap is CHF6.72B.
When is Evonik’s upcoming earnings report date?
Evonik’s upcoming earnings report date is Aug 04, 2026 which is in 33 days.
How were Evonik’s earnings last quarter?
Evonik released its earnings results on May 08, 2026. The company reported CHF0.313 earnings per share for the quarter, beating the consensus estimate of CHF0.281 by CHF0.032.
Is Evonik overvalued?
According to Wall Street analysts Evonik’s price is currently Undervalued.
Does Evonik pay dividends?
Evonik pays a Annually dividend of CHF0.851 which represents an annual dividend yield of 3.05%. See more information on Evonik dividends here
What is Evonik’s EPS estimate?
Evonik’s EPS estimate is 0.48.
How many shares outstanding does Evonik have?
Evonik has 466,000,000 shares outstanding.
What happened to Evonik’s price movement after its last earnings report?
Evonik reported an EPS of CHF0.313 in its last earnings report, beating expectations of CHF0.281. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evonik?
Currently, no hedge funds are holding shares in CH:EVK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Evonik Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
CHF16.02 (1.62% Upside)
CHF16.02 (1.62% Upside)
Blogger Sentiment
Bullish
CH:EVK Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth CHF273.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.75%
12-Months-Change
Fundamentals
Return on Equity
1.89%
Trailing 12-Months
Asset Growth
-8.82%
Trailing 12-Months
Company Description
Evonik
Evonik Industries AG operates primarily in the specialized chemicals market. Its business activities are structured across five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment is responsible for delivering essential ingredients such as polyurethane additives, modified silicones, isophorones, epoxy hardeners, oil modifiers, fumed silicas, matting agents, TAA compounds, and acetylenic diol-based surfactants, which find use in consumer products and various industrial applications. In the Nutrition & Care division, Evonik provides compounds like amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and their derivatives, synthetic products, pharmaceutical-grade polymers, and DL-methionine. These are crucial for consumer goods, animal nutrition, and healthcare industries. The Smart Materials segment manufactures advanced substances including hydrogen peroxide, peracetic acid, various activated nickel and precious metal catalysts (for powder, oil, and fat hydrogenation), amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, and different types of silicas (fumed and precipitated). These serve a broad spectrum of industries including automotive, paints, coatings, adhesives, and construction. Through its Performance Materials segment, the company produces polymer materials and intermediate chemicals, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbents, specifically for the rubber, plastics, and automotive sectors. Lastly, the Technology & Infrastructure segment provides crucial internal services, encompassing site management, utilities and waste disposal, technical expertise, process technology, engineering, and logistics. Evonik maintains a significant international presence, with operations spanning across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America. Founded in 1873, the firm's main offices are located in Essen, Germany, and it functions as a subsidiary of RAG-Stiftung.
EVK Stock 12 Month Forecast
Average Price Target
CHF16.02
▲(1.62% Upside)
Technical Analysis
Options Prices
Currently, No data available
---



